Daniel Prieto-Alhambra to Prevalence
This is a "connection" page, showing publications Daniel Prieto-Alhambra has written about Prevalence.
Connection Strength
0.148
-
COVID-19 in patients with autoimmune diseases: characteristics and outcomes in a multinational network of cohorts across three countries. Rheumatology (Oxford). 2021 10 09; 60(SI):SI37-SI50.
Score: 0.048
-
Validation of fragility fractures in primary care electronic medical records: A population-based study. Reumatol Clin (Engl Ed). 2019 Sep - Oct; 15(5):e1-e4.
Score: 0.037
-
Characteristics and Outcomes of Over 300,000 Patients with COVID-19 and History of Cancer in the United States and Spain. Cancer Epidemiol Biomarkers Prev. 2021 10; 30(10):1884-1894.
Score: 0.012
-
Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United Kingdom. Int J Obes (Lond). 2021 11; 45(11):2347-2357.
Score: 0.012
-
The natural history of symptomatic COVID-19 during the first wave in Catalonia. Nat Commun. 2021 02 03; 12(1):777.
Score: 0.011
-
Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study. Nat Commun. 2020 10 06; 11(1):5009.
Score: 0.011
-
Secular trends of use of anti-osteoporotic treatments in Spain: A population-based cohort study including over 1.5million people and more than 12years of follow-up. Bone. 2017 Dec; 105:292-298.
Score: 0.009
-
Prevalence of vertebral fracture and densitometric osteoporosis in Spanish adult men: The Camargo Cohort Study. J Bone Miner Metab. 2018 Jan; 36(1):103-110.
Score: 0.009